Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy
Objectives: Immunotherapy with BCG (Bacille Calmette-Guérin) after transurethral resection of the bladder tumor represents a highly effective primary treatment for intermediate and high-risk superficial bladder cancer. The effectiveness of this therapy has been documented, but its mechanism of actio...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2013-12-01
|
Series: | Archivio Italiano di Urologia e Andrologia |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/aiua/article/view/2210 |